FDAnews Devices

Menu
  • Home
  • Topics
  • Daily Buzz
  • Global Markets
  • Current Issue
  • 483s Online
  • Our Experts
Login
  • ABOUT US
  • CONTACT
  • ADVERTISE
Advanced Search
recent_searches
eu council/egypt/esubmitter/siemens healthineers 483/cfda sees increase adverse event reports
Home » Research & Development

Research & Development

Australia
Cost, Time to Market Top Industry Concerns in TGA Premarket Revisions
Aussie Government Jobs Plan Provides New Supports for MedTech Innovation

Brazil
Anvisa Seeks to Expand Public-Private Device Development Partnerships

United States
Final Guidance Clarifies U.S. FDA Ideas On Risk-Based Clinical Trial Monitoring
U.S. FDA Releasing More Trial Data Could Hasten Medtech Development

  • Topics
    • Regulatory Affairs
    • Quality
    • Audits & Inspections
    • Submissions & Approvals
    • Postmarket Safety
    • Research & Development
    • Commercial Operations
    • Advertising & Marketing
    • Intellectual Property
    • Software
    • Pricing & Reimbursement
  • Global Markets
    • Global
    • North America
    • Central & South America
    • Europe
    • Middle East
    • Asia/Pacific
    • Africa
  • Resource Center
  • Expert Analysis
  • Home
  • Contact us
  • About

MII logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 – Fax (703) 538-7676 – Toll free (888) 838-5578.

Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing